The Technical Advisory Group (TAG), an independent advisory panel of the World Health Organisation (WHO), has sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order to conduct a final Emergency Use Listing (EUL) risk-benefit assessment for global use of the vaccine.from https://ift.tt/3k0j94O
via IFTTT
No comments:
Post a Comment
Please Leave us a comment about our content, so that we can try improve our site Quality.